Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.3, 2011-02, pp. : 349-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sitagliptin/metformin fixed-dose combination: a guide to its use in type 2 diabetes mellitus

Drugs & Therapy Perspectives, Vol. 27, Iss. 9, 2011-09 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone

By Bailey Clifford J Green Brian D Flatt Peter R

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 1017-1025

Informa Healthcare

Access to resources Recommend Favorite

Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus

By Ono Yuri Kameda Hiraku Cho Kyu Yong

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 361-370

Informa Healthcare

Access to resources Recommend Favorite

Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus

By Inoue Masahiro

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2257-2268

Informa Healthcare

Access to resources Recommend Favorite

Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult Subjects: A Randomized, Open-Label, Crossover Study

By Migoya Elizabeth M.

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 855-866

Adis International

Access to resources Recommend Favorite